Used as a chiral building block in the synthesis of pharmaceutical intermediates, particularly in the development of protease inhibitors and other bioactive molecules. Its structure contains both a protected amine and a carboxylic acid functional group, making it suitable for peptide coupling and sequential derivatization in multi-step organic syntheses. The presence of the (R)-configuration is critical for stereoselective reactions, ensuring high enantiomeric purity in final active pharmaceutical ingredients (APIs). Commonly employed in research settings for drug discovery, especially in oncology and antiviral therapy.